E-Volve Systems’ President, Kevin Stout was recently invited to present at an event sponsored by ARMI/BioFab, IEEE, and Rockwell Automation entitled Automation and Data Management for the Manufacture of Tissue Engineering & Regenerative Medicine (TERM) Products. Kevin spoke to a large group of TERM experts about the benefits of automation and the proper process of planning automation implementation. The field of tissue engineering and regenerative medicine holds enormous potential to restore and improve damaged tissues, cartilage and even whole organs. The FDA has recently announced policy framework to facilitate and expedite the availability of therapies to patients with serious, or potentially life-threatening conditions. As this field continues to evolve, work is underway to make large-scale manufacturing of engineered tissues a reality. Our cutting-edge solutions support scalability and standardization of this process. We are excited to be part of an industry that will have such a positive impact on so many, and we look forward to adding value however we can in the advancement of this field.